This Study is To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule Combined With Allitinib Tablets in First-line Treatment of Advanced No-small Cell Lung Cancer
Latest Information Update: 27 Sep 2023
At a glance
- Drugs Allitinib (Primary) ; Catequentinib (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Dec 2020 New trial record